International Conference on Clinical Pharmacy and Personalized Medicine
ICCPPM
Official Invitation Letter Available
An official invitation letter will be provided upon successful registration for your participation in the conference.
Benefits of Registering as Listener
Access to All Conference Sessions
Plenary, keynote and parallel sessions
Networking Opportunities
Connect with global educators & researchers
Certificate of Participation
Digital certificate of participation
Invitation Letter Support
Official invitation letter after successful registration
Conference Kit / Digital Materials
E-proceedings & resource materials
Access to Keynote Sessions
Learn from leading experts & scholars
Conference Session Tracks
Aligned with UN Sustainable Development Goals
The conference's session tracks effectively support the following SDGs.
This track focuses on the latest developments in clinical pharmacology, emphasizing the role of pharmacists in optimizing patient outcomes. Discussions will include innovative practices and research that enhance medication management and safety.
SDG 3
SDG 4
This session will explore the critical contributions of pharmacists in ensuring patient safety through effective medication management. Topics will include risk assessment, error prevention strategies, and the integration of pharmacists in healthcare teams.
SDG 3
SDG 4
This track will delve into the essential functions of clinical pharmacy in therapeutic decision-making and patient care. Participants will discuss evidence-based practices and the impact of clinical pharmacists on treatment outcomes.
SDG 3
SDG 9
This session will highlight cutting-edge research in drug development and advanced drug delivery systems. Presentations will cover novel formulations, targeted therapies, and the role of technology in enhancing therapeutic efficacy.
SDG 3
SDG 9
This track will examine the implications of pharmacogenetics in tailoring medication regimens to individual patient profiles. Discussions will focus on genetic factors influencing drug response and the integration of personalized medicine into clinical practice.
SDG 3
SDG 9
This session will address the intersection of clinical immunology and pharmacotherapy, focusing on the management of immune-related conditions. Participants will explore the role of pharmacological interventions in modulating immune responses.
SDG 3
SDG 4
This track will investigate the pharmacological approaches to treating neurological and psychiatric disorders. Emphasis will be placed on the latest research in neuropharmacology and its implications for clinical practice.
SDG 3
SDG 4
This session will cover the principles of toxicology and their relevance to drug safety and efficacy. Topics will include risk assessment, adverse drug reactions, and the role of toxicology in clinical decision-making.
SDG 3
SDG 4
This track will focus on the study of drug utilization and its effects on population health. Participants will discuss methodologies in pharmacoepidemiology and the implications for public health policy.
SDG 3
SDG 9
This session will analyze current market trends in pharmacology, including drug pricing, access, and economic evaluations. Discussions will aim to understand the impact of market dynamics on clinical practice and patient care.
SDG 3
SDG 8
This track will explore the pharmacological treatments for ocular diseases and conditions. Presentations will include advancements in drug delivery systems for ophthalmic applications and their clinical implications.
SDG 3
SDG 4